Trial Details

UNKNOWN
Basic Information
Clinical ID c1219
Identifier NCT05386290
Trial Title A Multicentered Prospective Cohort Study of Chinese IBD Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Crohn Disease
Interventions DRUG: Infliximab|DRUG: Vedolizumab|DRUG: Ustekinumab|DRUG: conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
Participant Information
Sponsor Peking Union Medical College Hospital
City Beijing Municipality
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2020-07-09
Primary Completion Date 2023-09
Completion Date 2023-12